EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Ppy ‐lineage cells as a novel origin of pancreatic ductal adenocarcinoma

Ofejiro Blessing Pereye, Yuko Nakagawa, Takashi Sato, Ayako Fukunaka, Shuhei Aoyama, Yuya Nishida, Wakana Mizutani, Nanami Kobayashi, Yohei Morishita, Tetsunari Oyama, Reika Kawabata-Iwakawa, Hirotaka Watada und 3 weitere

The Journal of Pathology · 2024

DOI: 10.1002/path.6295 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pathology, 2024. Verfasst von Ofejiro Blessing Pereye und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Developmental Biology and Metabolism, Institute for Molecular and Cellular Regulation (IMCR), Gunma University, Gunma, Japan. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Cell Lineage. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Foundation for Promotion of Cancer Research, Gunma Foundation for Medicine and Health Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Ppy gene encodes pancreatic polypeptide (PP) secreted by PP‐ or γ‐cells, which are a subtype of endocrine cells localised mainly in the islet periphery. For a detailed characterisation of PP cells, we aimed to establish PP cell lines. To this end, we generated a mouse model harbouring the SV40 large T antigen (TAg) in the Rosa26 locus, which is expressed upon Ppy ‐promoter‐mediated Cre–loxP recombination. Whereas Insulin1 ‐ Cre ERT‐mediated TAg expression in beta cells resulted in insulinoma, surprisingly, Ppy ‐ Cre ‐mediated TAg expression resulted in the malignant transformation of Ppy ‐lineage cells. These mice showed distorted islet structural integrity at 5 days of age compared with normal islets. CK19 + duct‐like lesions contiguous with the islets were observed at 2 weeks of age, and mice developed aggressive pancreatic ductal adenocarcinoma (PDAC) at 4 weeks of age, suggesting that PDAC can originate from the islet/endocrine pancreas. This was unexpected as PDAC is believed to originate from the exocrine pancreas. RNA‐sequencing analysis of Ppy ‐lineage islet cells from 7‐day‐old TAg + mice showed a downregulation and an upregulation of endocrine and exocrine genes, respectively, in addition to the upregulation of genes and pathways associated with PDAC. These results suggest that the expression of an oncogene in Ppy ‐lineage cells induces a switch from endocrine cell fate to PDAC. Our findings demonstrate that Ppy ‐lineage cells may be an origin of PDAC and may provide novel insights into the pathogenesis of pancreatic cancer, as well as possible therapeutic strategies. © 2024 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsCell LineageAnimalsMiceMice, TransgenicCell Transformation, NeoplasticIslets of LangerhansAntigens, Polyomavirus TransformingGene Expression Regulation, NeoplasticHumans

Stichwörter der Autor:innen

PDACPpy geneSV40 large Tendocrine pancreasisletspancreatic cancerpancreatic polypeptide

Substanzen

Antigens, Polyomavirus Transforming

Autor:innen und Institutionen

  • Laboratory of Developmental Biology and Metabolism, Institute for Molecular and Cellular Regulation (IMCR), Gunma University, Gunma, Japan.
  • Department of Metabolism & Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Laboratory for Analytical Instruments, Education and Research Support Centre, Gunma University Graduate School of Medicine, Gunma, Japan.
  • Department of Diagnostic Pathology, Gunma University Graduate School of Medicine, Gunma, Japan.
  • Division of Integrated Oncology Research, Gunma University Initiative for Advanced Research, Gunma, Japan.
  • Department of Pathology and Molecular Medicine, Biomedical Research Centre, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

ORCID-Profile: Hiroki Mizukami, Yoshio Fujitani

Förderung

  • Japan Society for the Promotion of Science
  • Foundation for Promotion of Cancer Research
  • Gunma Foundation for Medicine and Health Science
  • The NOVARTIS Foundation

Zitieren

APA

Pereye, O. B., Nakagawa, Y., Sato, T., Fukunaka, A., Aoyama, S., Nishida, Y., Mizutani, W., Kobayashi, N., Morishita, Y., Oyama, T., Kawabata-Iwakawa, R., Watada, H., Mizukami, H., Fukuda, A., & Fujitani, Y. (2024). Identification of Ppy ‐lineage cells as a novel origin of pancreatic ductal adenocarcinoma. The Journal of Pathology. https://doi.org/10.1002/path.6295

Vancouver

Pereye OB, Nakagawa Y, Sato T, Fukunaka A, Aoyama S, Nishida Y, et al. Identification of Ppy ‐lineage cells as a novel origin of pancreatic ductal adenocarcinoma. The Journal of Pathology. 2024. doi:10.1002/path.6295

BibTeX
@article{Pereye2024,
  author = {Pereye, Ofejiro Blessing and Nakagawa, Yuko and Sato, Takashi and Fukunaka, Ayako and Aoyama, Shuhei and Nishida, Yuya and Mizutani, Wakana and Kobayashi, Nanami and Morishita, Yohei and Oyama, Tetsunari and Kawabata-Iwakawa, Reika and Watada, Hirotaka and Mizukami, Hiroki and Fukuda, Akihisa and Fujitani, Yoshio},
  title = {Identification of Ppy ‐lineage cells as a novel origin of pancreatic ductal adenocarcinoma},
  journal = {The Journal of Pathology},
  year = {2024},
  doi = {10.1002/path.6295}
}
Kostenlos starten →